Welcome to MS Views and News blog


MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

April 12, 2018

Vitamin D supplementation recommended in all children, teens

  • Pediatric MS
    /
SAN FRANCISCO – Vitamin D deficiency is common among children and adolescents, particularly those with chronic disease, Catherine Gordon, MD, said…
Pediatric MS

April 12, 2018

Why NICE Didn’t Approve Roche’s Ocrevus for Multiple Sclerosis

  • Marketing
    /
By Sarah Collins Apr 12, 2018 | 9:38 AM Overview On April 5, 2018, Roche’s (RHHBY) MS (multiple sclerosis) drug…
Marketing

April 11, 2018

Searching for MS Genes

  • MS Genetic Research
    /
Research suggests that MS occurs in individuals and in families whose genes make them susceptible to developing the disease, and…
MS Genetic Research

April 11, 2018

Frequently Asked Questions: Generic and Biosimilar – Medications

  • MS Drug Therapies
    /
What is a generic medication? A generic medication is a product that is equivalent to a brand-name medication whose patent protections have…
MS Drug Therapies

April 11, 2018

What Is Glatiramer Acetate / What Is Mylan’s Glatiramer Acetate Injection?

  • MS Drug Therapies
    /
Glatiramer acetate is a prescription medication that can be injected subcutaneously to treat relapsing forms of multiple sclerosis (MS). Every…
MS Drug Therapies

April 11, 2018

Video: The MS Improvement Project

  • Boster's MS Corner
    /
Did you know that some MS patients manifest IMPROVEMENTS to disability? It’s true, and I’m amazed that no one seems…
Boster's MS Corner

April 11, 2018

Mylan to Acquire the Global Marketing Rights to a Once-monthly Glatiramer Acetate Product through an Investment and Partnership with Israeli Company Mapi Pharma

  • MS Drug Therapies
    /
Once approved, this product could represent a significant milestone for patients with relapsing-remitting multiple sclerosis Mapi Pharma has completed an…
MS Drug Therapies

April 10, 2018

Lesion accumulation is predictive of long-term cognitive decline in multiple sclerosis.

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
Mult Scler Relat Disord. 2018 Mar 6;21:110-116. doi: 10.1016/j.msard.2018.03.002. [Epub ahead of print] Ouellette R1, Bergendal Å2, Shams S3, Martola J3, Mainero C4, Kristoffersen Wiberg M3, Fredrikson…
MS Research Study and Reports

April 10, 2018

Treatment of seizures for patients with multiple sclerosis

  • Multiple Sclerosis (MS) Symptoms
    /
First published: July 8, 2009. Link to full article: [Cochrane Library] Plain language summary Epileptic seizures occur in a relatively small…
Multiple Sclerosis (MS) Symptoms

April 10, 2018

The Effectiveness and Risks of Cranial Electrical Stimulation for the Treatment of Pain, Depression, Anxiety, PTSD, and Insomnia: A Systematic Review [Internet].

  • Misc. Tips - Non MS Related
    /
Shekelle P, Cook I, Miake-Lye IM, Mak S, Booth MS, Shanman R, Beroes JM. Source Washington (DC): Department of Veterans Affairs (US); 2018 Feb.VA Evidence-based Synthesis…
Misc. Tips - Non MS Related

Categories

Latest Blog Posts